Preliminary reports suggest conolidine may possibly inhibit distinct ion channels, reducing neuronal excitability and restricting ache indicators. This mechanism is particularly pertinent in neuropathic discomfort, the place irregular signaling causes persistent discomfort. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR)